Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 · New England Journal of Medicine · 5,033 citations
https://doi.org/10.1056/nejmoa033025
A
A. Harstrick
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
184
Papers
10.7K
Citations
38
h-index
88
i10-index
A. Harstrick is an academic researcher from Affimed Therapeutics (Germany). The author has contributed to research in topics: Testicular diseases and treatments & Cancer Treatment and Pharmacology & Colorectal Cancer Treatments and Studies. The author has an h-index of 38, co-authored 157 publications.
Papers by this author
worksComparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP)
1997 · Annals of Oncology · 72 citations
https://doi.org/10.1023/a:1008290406221
Carbamoylation of glutathione reductase by n,n-bis(2-chloroethyl)-n-nitrosourea associated with inhibition of multidrug resistance protein (MRP) function
1997 · Biochemical Pharmacology · 34 citations
https://doi.org/10.1016/s0006-2952(97)00010-5
Reversal of MDR1-associated resistance to topotecan by PAK-200S, a new dihydropyridine analogue, in human cancer cell lines
1999 · British Journal of Cancer · 26 citations
https://doi.org/10.1038/sj.bjc.6694384
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat